Skip to main content
F1000Research logoLink to F1000Research
. 2016 May 4;4:231. Originally published 2015 Jul 13. [Version 2] doi: 10.12688/f1000research.6778.2

Enteropathogenic E. coli: breaking the intestinal tight junction barrier

Anand Prakash Singh 1, Saima Aijaz 1,a
PMCID: PMC4870986  PMID: 27239268

Version Changes

Revised. Amendments from Version 1

In version 2, we have incorporated the suggestions of Prof. Dudeja (Reviewer #1) and have (i) outlined the effect of EPEC on the disruption of ion channels and transporters in the beginning of the discussion section; (ii) included a discussion on the role the EPEC effector EspG on Cl - absorption in host cells; (iii) discussed the microtubule-dependent effect of EspG1/G2 on tight junction barrier function and (iv) included references # 5, 13, 15,16, 34 and 35 in the reference section in support of the above.

Abstract

Enteropathogenic E. coli (EPEC) causes acute intestinal infections in infants in the developing world. Infection typically spreads through contaminated food and water and leads to severe, watery diarrhea. EPEC attaches to the intestinal epithelial cells and directly injects virulence factors which modulate multiple signaling pathways leading to host cell dysfunction. However, the molecular mechanisms that regulate the onset of diarrhea are poorly defined. A major target of EPEC is the host cell tight junction complex which acts as a barrier and regulates the passage of water and solutes through the paracellular space. In this review, we focus on the EPEC effectors that target the epithelial barrier, alter its functions and contribute to leakage through the tight junctions.

Keywords: Enteropathogenic E. coli, tight junctions, paracellular permeability.

Introduction

EPEC causes diarrhea in infants in developing countries and is a major cause of morbidity and mortality 1, 2. EPEC infection results in excessive loss of water and electrolytes from the body leading to dehydration and death 3. However, the underlying molecular mechanisms are not completely understood. EPEC has been reported to disrupt the ion transporters and channels as well as tight junctions in intestinal epithelial cells leading to rapid onset of diarrhea 4, 5. EPEC directly injects virulence factors into the host cells which target multiple signaling pathways and some have been linked to tight junction disruption 6. In this review, we focus only on the EPEC effectors reported to be involved in the disruption of tight junctions.

Discussion

EPEC attaches to the apical surface of the intestinal epithelial cells and effaces the microvilli causing localized lesions 7, 8. EPEC uses a type three secretion system to inject at least twenty five effector proteins into the host cells 9. Many of the effectors are encoded by genes located on a pathogenicity island called the locus of enterocyte effacement (LEE) although non-LEE encoded effectors have also been identified 10. Intimate attachment of the bacterium to the host cell is facilitated by the effector, Tir (Translocated intimin receptor) which is inserted into the host plasma membrane where it serves as a receptor for intimin, the outer surface protein of EPEC 11.

Recent studies have revealed that the rapid onset of diarrhea in EPEC infections is a result of increased intestinal secretion as well as reduced absorption of ions and solutes 5. EPEC uses several effectors to disable the ion transport systems in host intestinal cells. The EPEC effector EspF inactivates the sodium-D-glucose co-transporter SGLT-1 through co-operative actions of other EPEC effectors Map, Tir and intimin and also inhibits the activity of the Na +/H + exchanger NHE3 12, 13. Map and the effector NleA interact with Na +/H + exchanger regulatory factor 2 (NHERF2) altering its function 14. The net result of these effector actions is reduced uptake of Na + into the cells. EPEC also inhibits Cl - absorption in intestinal epithelial cells by downregulation of the Cl -/HCO 3 - exchanger SLC26A3 also known as DRA (downregulated in adenoma) 15, 16. This process is mediated by the effectors EspG1 and G2 in a microtubule-dependent manner as disruption of the microtubules results in a decrease in the levels of DRA at the apical surface of host cells 16. These data indicate that EPEC increases the endocytosis of DRA and also prevents its recycling to the apical surface by inhibiting exocytosis 16.

In addition to their effects on ion absorption, EPEC effectors also disrupt host cell functions by cytoskeletal reorganization, mitochondrial dysfunction, protein transport defects, suppression of immune responses and epithelial barrier disruption 9. Since the barrier function is regulated by the intestinal epithelial tight junctions, EPEC-mediated disruption of this complex also contributes to the onset of diarrhea.

Tight junctions seal adjacent epithelial cells and act as (i) a gate that selectively regulates the passage of ions and solutes through the paracellular space and (ii) a fence that prevents the intermixing of apical and basal plasma membrane proteins thereby maintaining cell polarity 17, 18. The tight junction complex consists of transmembrane proteins, adaptor proteins, small GTPases, kinases, phosphatases, transcriptional and post-transcriptional regulators 17, 18. The transmembrane proteins regulate cell-cell adhesion and are linked to the cytoskeleton through the adaptor proteins 17, 18. Paracellular permeability is regulated by the transmembrane proteins belonging to the Marvel-domain containing protein family (occludin, Tricellulin/MarvelD2 and MarvelD3) as well as by members of the claudin family 17, 19. Additionally, permeability is regulated by tight junction-associated guanine-nucleotide exchange factors for Rho GTPases through the modulation of the actin cytoskeleton 1719.

Leakage through tight junctions occurs in diarrhea and the EPEC effectors EspF, Map, EspG1/G2 and NleA have been implicated in the disruption of host cell tight junctions 2022.

EspF is a multifunctional effector which disrupts the tight junction barrier 20. The N-terminus of EspF contains mitochondrial and nucleolus targeting sequences which direct EspF to the mitochondria and nucleolus respectively where it alters their functions 23. The C-terminus of EspF contains three proline rich repeats with binding sites for eukaryotic sorting nexin 9 (SNX9) and neuronal Wiskott-Aldrich syndrome protein (N-WASP) 23. Binding of EspF with SNX9 is required for its recruitment to the plasma membrane but is not sufficient for tight junction disruption as EspF mutants deficient in SNX9 binding also disrupt tight junctions 24. Binding of EspF with N-WASP triggers the activation of the Arp2/3 complex leading to actin polymerization 24. EspF from the rabbit EPEC strain E22 has been shown to bind actin and recruit the tight junction proteins ZO-1 and ZO-2 into actin pedestals 25 while EspF from the mouse EPEC strain C. rodentium is involved in the internalization of claudin-1, -3 and -5 in vivo 26 causing tight junction disruption.

The EPEC effector Map cooperates with EspF in the disruption of tight junctions 20. Like EspF, Map is also targeted to the mitochondria where it alters mitochondrial functions 20. Map activates the Cdc42 GTPase by functioning as its GEF (guanine-nucleotide exchange factor) leading to the formation of transient filopodia 27. The C-terminus of Map contains a TRL (Thr-Arg-Leu) motif through which it interacts with EBP50 (ERM-binding phosphoprotein 50) also called Na +/H + exchanger regulatory factor 1 (NHERF1) 28. Binding with EBP50 recruits the actin scaffold protein ezrin to this complex linking Map to the actin cytoskeleton. The precise mechanism by which Map disrupts tight junctions is not known but it likely occurs through the modulation of the actin cytoskeleton.

NleA has been reported to increase paracellular permeability by disrupting the tight junction proteins ZO-1 and occludin 22. NleA inhibits protein secretion from the ER (endoplasmic reticulum) to the Golgi by direct interaction with Sec24, a subunit of the coat protein complex II (COP-II) 29. It has been proposed that NleA inhibits the transport of newly synthesized tight junction proteins disrupting the barrier.

The EPEC effector EspG and its homolog EspG2 have been shown to increase the permeability of small tracers through the tight junctions 21. EspG binds the Golgi matrix protein GM130 disrupting the Golgi structure 30. Additionally, EspG deregulates the small GTPases Arf1/6 (ADP ribosylation factor 1/6) and Rab1 causing arrest of protein trafficking from the ER to the Golgi 31, 32. EspG binds p21-activated kinase at the same site required for Rab1 binding 32, 33 linking the microtubules to this signaling axis. Recent studies have shown that EspG1 and G2 not only disrupt the microtubules causing internalization of occludin but also inhibit the recovery of tight junctions in calcium switch experiments 34, 35 indicating that EspG regulates multiple signaling pathways ultimately disrupting tight junctions.

Finally, EspF and EspG have also been implicated in the internalization of aquaporins-2 and -3, leading to reduced water absorption 36.

Conclusions

Coordinated actions of the EPEC effectors EspF, Map, NleA and EspG disrupt tight junctions. With the exception of EspF, which forms a complex with ZO-1/ZO-2, none of the other effectors have been reported to interact with any tight junction protein. Therefore, their role in the disruption of tight junctions and onset of diarrhea is possibly due to (i) modulation of the actin cytoskeleton (EspF, Map) or the microtubules (EspG); (ii) inhibition of protein trafficking from the ER to the Golgi (EspG, NleA); (iii) inhibition of tight junction restoration (EspG); (iv) interference with the functions of the Na +/H + exchanger 3 (EspF), SGLT-1 (EspF, Map), NHERF-1, -2 (Map, NleA), DRA (EspG1/G2) and (v) deregulation of aquaporins (EspF, EspG).

Funding Statement

The author(s) declared that no grants were involved in supporting this work.

[version 2; referees: 2 approved]

References

  • 1. Lanata CF, Fischer-Walker CL, Olascoaga AC, et al. : Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One. 2013;8(9):e72788. 10.1371/journal.pone.0072788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ochoa TJ, Contreras CA: Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24(5):478–483. 10.1097/QCO.0b013e32834a8b8b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Nataro JP, Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11(1):142–201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Guttman JA, Finlay BB: Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol. 2008;16(11):535–542. 10.1016/j.tim.2008.08.004 [DOI] [PubMed] [Google Scholar]
  • 5. Viswanathan VK, Hodges K, Hecht G: Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol. 2009;7(2):110–119. 10.1038/nrmicro2053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Dean P, Kenny B: The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol. 2009;12(1):101–109. 10.1016/j.mib.2008.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Vallance BA, Finlay BB: Exploitation of host cells by enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2000;97(16):8799–8806. 10.1073/pnas.97.16.8799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Wong AR, Pearson JS, Bright MD, et al. : Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011;80(6):1420–1438. 10.1111/j.1365-2958.2011.07661.x [DOI] [PubMed] [Google Scholar]
  • 9. Dean P, Maresca M, Kenny B: EPEC’s weapons of mass subversion. Curr Opin Microbiol. 2005;8(1):28–34. 10.1016/j.mib.2004.12.010 [DOI] [PubMed] [Google Scholar]
  • 10. Iguchi A, Thomson NR, Ogura Y, et al. : Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol. 2009;191(1):347–354. 10.1128/JB.01238-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Frankel G, Phillips AD: Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol. 2008;10(3):549–556. 10.1111/j.1462-5822.2007.01103.x [DOI] [PubMed] [Google Scholar]
  • 12. Dean P, Maresca M, Schüller S, et al. : Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A. 2006;103(6):1876–1881. 10.1073/pnas.0509451103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hodges K, Alto NM, Ramaswamy K, et al. : The Enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol. 2008;10(8):1735–1745. 10.1111/j.1462-5822.2008.01163.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Martinez E, Schroeder GN, Berger CN, et al. : Binding to Na +/H + exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. Cell Microbiol. 2010;12(12):1718–1731. 10.1111/j.1462-5822.2010.01503.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gill RK, Borthakur A, Hodges K, et al. : Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with Enteropathogenic E. coli. J Clin Invest. 2007;117(2):428–437. 10.1172/JCI29625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Gujral T, Kumar A, Priyamvada S, et al. : Mechanisms of DRA recycling in intestinal epithelial cells: effect of Enteropathogenic E. coli. Am J Physiol Cell Physiol. 2015;309(12):C835–C846. 10.1152/ajpcell.00107.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Aijaz S, Balda MS, Matter K: Tight junctions: molecular architecture and function. Int Rev Cytol. 2006;248:261–298. 10.1016/S0074-7696(06)48005-0 [DOI] [PubMed] [Google Scholar]
  • 18. Van Itallie CM, Anderson JM: Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol. 2014;36:157–165. 10.1016/j.semcdb.2014.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Krug SM, Schulzke JD, Fromm M: Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–176. 10.1016/j.semcdb.2014.09.002 [DOI] [PubMed] [Google Scholar]
  • 20. Dean P, Kenny B: Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol. 2004;54(3):665–675. 10.1111/j.1365-2958.2004.04308.x [DOI] [PubMed] [Google Scholar]
  • 21. Matsuzawa T, Kuwae A, Abe A: Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect Immun. 2005;73(10):6283–6289. 10.1128/IAI.73.10.6283-6289.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Thanabalasuriar A, Koutsouris A, Weflen A, et al. : The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol. 2010;12(1):31–41. 10.1111/j.1462-5822.2009.01376.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Holmes A, Mühlen S, Roe AJ, et al. : The EspF effector, a bacterial pathogen’s Swiss army knife. Infect Immun. 2010;78(11):4445–4453. 10.1128/IAI.00635-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Alto NM, Weflen AW, Rardin MJ, et al. : The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J Cell Biol. 2007;178(7):1265–1278. 10.1083/jcb.200705021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Peralta-Ramirez J, Hernandez JM, Manning-Cela R, et al. : EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability. Infect Immun. 2008;76(9):3854–3868. 10.1128/IAI.00072-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Guttman JA, Li Y, Wickham ME, et al. : Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol. 2006;8(4):634–645. 10.1111/j.1462-5822.2005.00656.x [DOI] [PubMed] [Google Scholar]
  • 27. Huang Z, Sutton SE, Wallenfang AJ, et al. : Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol. 2009;16(8):853–860. 10.1038/nsmb.1647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Simpson N, Shaw R, Crepin VF, et al. : The Enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Mol Microbiol. 2006;60(2):349–363. 10.1111/j.1365-2958.2006.05109.x [DOI] [PubMed] [Google Scholar]
  • 29. Kim J, Thanabalasuriar A, Chaworth-Musters T, et al. : The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe. 2007;2(3):160–171. 10.1016/j.chom.2007.07.010 [DOI] [PubMed] [Google Scholar]
  • 30. Clements A, Smollett K, Lee SF, et al. : EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function. Cell Microbiol. 2011;13(9):1429–1439. 10.1111/j.1462-5822.2011.01631.x [DOI] [PubMed] [Google Scholar]
  • 31. Dong N, Zhu Y, Lu Q, et al. : Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell. 2012;150(5):1029–1041. 10.1016/j.cell.2012.06.050 [DOI] [PubMed] [Google Scholar]
  • 32. Selyunin AS, Reddick LE, Weigele BA, et al. : Selective protection of an ARF1-GTP signaling axis by a bacterial scaffold induces bidirectional trafficking arrest. Cell Rep. 2014;6(5):878–891. 10.1016/j.celrep.2014.01.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Germane KL, Spiller BW: Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase. Biochemistry. 2011;50(6):917–919. 10.1021/bi1020138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Glotfelty LG, Hecht GA: Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms. Ann N Y Acad Sci. 2012;1258:149–158. 10.1111/j.1749-6632.2012.06563.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Glotfelty LG, Zahs A, Hodges K, et al. : Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration. Cell Microbiol. 2014;16(12):1767–1783. 10.1111/cmi.12323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Guttman JA, Samji FN, Li Y, et al. : Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell Microbiol. 2007;9(1):131–141. 10.1111/j.1462-5822.2006.00773.x [DOI] [PubMed] [Google Scholar]
F1000Res. 2016 May 13. doi: 10.5256/f1000research.9314.r13852

Referee response for version 2

Pradeep Dudeja 1

The authors have appropriately revised the manuscript and have addressed all of the concerns of this reviewer

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

F1000Res. 2016 Jan 6. doi: 10.5256/f1000research.7282.r11552

Referee response for version 1

Fernando Navarro-Garcia 1

This is an interesting review, and I think it makes a positive review to the current knowledge about the effects of EPEC on the tight junctions. However, it will be interesting to note the observations posted by the first reviewer (Dr. Dudeja).

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

F1000Res. 2016 Apr 17.
Saima Aijaz 1

Thank you for your comments. I have now amended the review to incorporate the suggestions of Prof. Dudeja.

F1000Res. 2015 Oct 5. doi: 10.5256/f1000research.7282.r10659

Referee response for version 1

Pradeep Dudeja 1

  1. The first sentence conveys the wrong message.  EPEC does not cause 1 million deaths but as quoted reference 1, it causes an average of 79000 dealth/year.  The overall deaths due to diarrheal diseases are about 1 million/year.

  2. The authors should first outline the mechanisms of EPEC induced diarrhea including recent work on NaCl absorption than focus on tight junctions.

  3. The authors should refer to the recent papers on EPEC effects on tight junctions e.g. Glotfelty et al. Cell Microbiol. 2014

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

F1000Res. 2015 Oct 6.
Saima Aijaz 1

Thank you for your comments Prof. Dudeja. We are working on addressing the issues raised by you and will incorporate them in the revised version.

F1000Res. 2016 Apr 17.
Saima Aijaz 1

Thank you for your valuable comments. I have now addressed the concerns you had and have incorporated the literature and references related to Cl - absorption as well as references by Glotfelty et al. I appreciate your comments as they have helped me to broaden the focus of this review and helped to highlight the importance of the disruption of ion channels and transporters by EPEC.


Articles from F1000Research are provided here courtesy of F1000 Research Ltd

RESOURCES